Additionally, the 36-month beta value for PFE is 0.65. There are mixed opinions on the stock, with 11 analysts rating it as a “buy,” 1 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”
The public float for PFE is 5.66B and currently, short sellers hold a 1.32% ratio of that float. The average trading volume of PFE on September 27, 2024 was 31.31M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PFE) stock’s latest price update
Pfizer Inc. (NYSE: PFE)’s stock price has gone rise by 0.41 in comparison to its previous close of 28.97, however, the company has experienced a -1.12% decrease in its stock price over the last five trading days. zacks.com reported 2024-09-27 that Unlock your portfolio value by investing in these high-earnings stocks like PPC, PFE, IAG and ASIX.
PFE’s Market Performance
Pfizer Inc. (PFE) has seen a -1.12% fall in stock performance for the week, with a 1.18% gain in the past month and a 3.97% surge in the past quarter. The volatility ratio for the week is 1.77%, and the volatility levels for the past 30 days are at 1.95% for PFE. The simple moving average for the last 20 days is -0.41% for PFE’s stock, with a simple moving average of 3.40% for the last 200 days.
Analysts’ Opinion of PFE
Guggenheim gave a rating of “Buy” to PFE, setting the target price at $36 in the report published on February 23rd of the current year.
PFE Trading at -0.85% from the 50-Day Moving Average
After a stumble in the market that brought PFE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.72% of loss for the given period.
Volatility was left at 1.95%, however, over the last 30 days, the volatility rate increased by 1.77%, as shares surge +1.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.24% lower at present.
During the last 5 trading sessions, PFE fell by -1.27%, which changed the moving average for the period of 200-days by +1.41% in comparison to the 20-day moving average, which settled at $29.22. In addition, Pfizer Inc. saw 1.04% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PFE starting from DAMICO JENNIFER B., who sale 5,154 shares at the price of $28.66 back on Aug 13 ’24. After this action, DAMICO JENNIFER B. now owns 8,582 shares of Pfizer Inc., valued at $147,714 using the latest closing price.
Gottlieb Scott, the Director of Pfizer Inc., purchase 3,000 shares at $26.47 during a trade that took place back on Dec 15 ’23, which means that Gottlieb Scott is holding 9,000 shares at $79,401 based on the most recent closing price.
Stock Fundamentals for PFE
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.49 for the gross margin
The net margin for Pfizer Inc. stands at -0.05. The total capital return value is set at 0.01. Equity return is now at value -2.78, with -1.19 for asset returns.
Based on Pfizer Inc. (PFE), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.79. The interest coverage ratio of the stock is 0.54.
Currently, EBITDA for the company is 10.53 billion with net debt to EBITDA at 8.26. When we switch over and look at the enterprise to sales, we see a ratio of 4.2. The receivables turnover for the company is 4.88for trailing twelve months and the total asset turnover is 0.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.86.
Conclusion
In conclusion, Pfizer Inc. (PFE) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
